MOM A K Omar
M A K Omar
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
M A K Omar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Akram Salim Echtay
Internal Medicine Department, Head Division of Endocrinology, Rafic Hariri University Hospital, Bir Hassan, Jinah, POB: 5244, 2833-7401, Beirut, Lebanon
1 shared publication - Kadriye Kaplan
Novo Nordisk A/S, Vandtaarnsvej 114, DK 2860, Søborg, Denmark
1 shared publication M Wadee
Muslim Stats South Africa, Johannesburg, South Africa
1 shared publication- Magnus Ekelund
Novo Nordisk A/S, Søborg, Denmark
1 shared publication - Mohamed Hassanein
Mohamed Bin Rashid University and Dubai Hospital, Dubai, United Arab Emirates
1 shared publication - Nor Azmi Kamaruddin
Endocrine Unit, Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Kuala Lumpur, Malaysia
1 shared publication
Latest Publications
- Open Access
- 14 July 2021
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 111 (9) , 818
A call to action: Temporal trends of COVID-19 deaths in the South African Muslim community
A call to action: Temporal trends of COVID-19 deaths in the South African Muslim community
- 14 July 2021
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 111 (9) , 818
Open AccessA call to action: Temporal trends of COVID-19 deaths in the South African Muslim community
A call to action: Temporal trends of COVID-19 deaths in the South African Muslim community
- Open Access
- 1 January 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 135, 218-226
Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan
- 1 January 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 135, 218-226
Open AccessOriginal paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan